Look at those stoopid Monctonians

Stephane Dion was quite disturbed by how stupid Monctonians were when he spent six months here in the early 1980s.

There must be a few bright Monctonian…

Moncton researchers find biomarker for prostate cancer

Cancer researchers in Moncton have developed a tool they say will eventually identify prostate cancer earlier and more accurately than standard tests.

Dr. Rodney Ouellette, who is part Atlantic Cancer Research Institute, leads a team of scientists that he said has come up with a biomarker — a series of telltale genes that always appear to be active in people with prostate cancer.

It took the scientist three years to whittle down the 20,000 genes in the human genome to find the eight genes that have repeatedly shown up in men with prostate cancer.

And if that ain’t smart enough for ya, check out this.

This entry was posted in Uncategorized. Bookmark the permalink.

0 Responses to Look at those stoopid Monctonians

  1. Anonymous says:

    I hate to rain on your parade but a LOT of scientists have tried finding markers for cancers and there are a LOT of press releases that say things like ‘could’ and ‘hope to’. That’s standard in trying to drum up funding and investors. So far the only real successful marker is the BRCA 1 test for breast cancer, and that was a long time coming. Hopefully this can lead to something though, but from somebody in the industry I can tell you he’s got a hard slog to find investors. I know companies and scientists that have a hell of a lot more papers, studies, and patents than he does who are finding it hard to get into doors. This is the guy, I believe, who is featured in the Moncton economic study recently released who claims that he doesn’t even know how to go about commercializing his ‘product’ and so wants the incubator set up to do it for him. That’s not how it works in the biotech world. If he doesn’t know how to ‘sell’, he’d better learn quick. Prostate cancer is one of the hugest markets and therefore most research competitive cancers out there. But hope springs eternal.

    However, I love acadieman, even if he is a clear rip off of Dark Horse Comics ‘Mystery Men’. Any idea where the DVD is available? Do they have a website?

  2. blind leading the blind says:

    Obviously, mr anonymous doesn’t know much about biomedical R&D. Everything has to start with research and discovery. Validation and testing are the next steps. For something to become ‘could’ and ‘hope to’ takes years of work. These things don’t just jump out of a test tube. Regulatory requirements and clinical trials are then required to make sure the discoveries actually work and improve the health of patients. These steps cannot be bypassed or otherwise we have situations like Vioxx occuring. BRCA 1 is not the only successful marker. BCRA1 and BCRA2 are genes that predict your predisposition to breast and other types of cancer. There are dozens if not hundreds of other genes that are being investigated as tools for early detection, screening, accurate diagnosis and therapeutic targets. Perhaps you have not heard of Her2/neu(Herceptin), BCR/ABL (Gleevec), VEGF (Avastin), etc and I could keep going for hours.

    Science and Investment are not one in the same. It takes decades to become a credible scientist. You would dismiss this person’s efforts because he is not an investment banker as well? Perhaps if you are so bright, why not offer your investment savvy to bring these ideas to market. I am sure they are very busy and would appreciate the savoir faire of a volunteer biotech investment guru. Get a grip! Do you have the slightest idea of how many full time biomedical researchers we have in NB? And you would have them divert from their research so that they can take up courses in business and investment. Hey, while they are at it, they should get their pilots license so they can deliver the new discoveries directly to to big pharma companies. Better yet, I would advise them to use their planes to get the hell out of this loser province with attitudes like these. NB would need a hell of a lot more R&D and breakthroughs in the knowledge industry to prevent it from dying. Our demographics are crushing us, we cannot attract immigrants here to cut trees and fish so we might as well find some R&D to invest in otherwise it will be RIP.